Finanzen von GlucoTrack Inc (GCTK)GCTKGlucoTrack Inc

Evaluating the bottom line, GlucoTrack Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -620.63%, provide a clear picture of how effectively GCTK converts its operational activities into shareholder value.

In the context of the broader market, GCTK competes directly with industry leaders such as BBLG and NUWE. With a market capitalization of $2.43M, it holds a leading position in the sector. When comparing efficiency, GCTK's gross margin of N/A stands against BBLG's N/A and NUWE's 76.08%. Such benchmarking helps identify whether GlucoTrack Inc is trading at a premium or discount relative to its financial performance.

GlucoTrack has reported consistent financial losses, with a net income of -4,000,000 USD in Q2 2026 and an EPS of -11.42, indicating ongoing financial struggles. The company's total equity is negative, at -1,741,000 USD as of Q2 2026, which raises concerns about its financial health.